We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transgenic Plants Produce Cervical Cancer Vaccine

By Biotechdaily staff writers
Posted on 29 Aug 2003
German researchers have genetically engineered plants to produce 15 virus-like particles of the human papillomavirus (HPV) that could be used in the creation of vaccines or as edible vaccines themselves for cervical cancer. More...
Their work was reported in the September 2003 issue of the Journal of Virology.

Cervical cancer is linked to infection with HPV. Because it is the third most common cancer among women, there is a strong need for the development of an HPV preventive vaccine. In the study, tobacco and potato plants were genetically engineered to produce a major structural protein of HPV. When the protein was purified and administered to mice, it induced an immune response. When the potatoes were fed to mice, they also induced an immune response, although not as significant.

"Here, we demonstrated as a first step that it is possible to produce transgenic plants expressing the HPV 16 L1 protein in a form appropriate for immunization purposes,” said the researchers, from the Max Planck Institute in Golm (Germany).




Related Links:
Max Planck

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Immunofluorescence Analyzer
IFA System
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.